This study did not find a causal association between SGLT2 inhibition and depression, anxiety disorder, schizophrenia, obsessive-compulsive disorder, or bipolar affective disorder (Figure 3 and Table S7). Here, SLC5A2 is linked to depressive symptom measurement.